-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
June 07, 2013 - Overall
Benefits and Harms of
OCs
(pg.211) Page 245. Table 59. … Overall
Benefits and Harms of
OCs
(pg. 229) Figure 52 - Y axis is unclear. … Overall
Benefits and Harms of
OCs
(pg. 230, table 62?) … Overall
Benefits and Harms of
OCs
(pg. 251-253) Figure 81-84. … Overall
Benefits and Harms of
OCs
The future research sections are clear.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
October 26, 2012 - Harms
were not reported. … Harms were not reported.
ES-2
Table A. … Harms
were not reported. … Harms were not reported.
3
Table 1. … Harms were not reported.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ems-blood-transfusion-protocol-amendment.pdf
February 04, 2025 - Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-preventive-services-executive-summary.pdf
June 01, 2022 - -
efficacy, post-traumatic stress disorder, and safety behaviors (low SOE), and
unclear evidence on harms … utilization.
• Studies did not adequately evaluate factors related to access, health equity, or
potential harms … Data on harms was extremely limited for
IPV and not addressed in studies of contraceptive care. … Number of
Studies;* Study
Design;
Participants (n) Overall Effect
Strength
of
Evidence
Harms … family planning or STI counseling or evaluated factors related to access, health equity, or
potential harms
-
effectivehealthcare-admin.ahrq.gov/products/abnormal-uterine-bleeding/research
December 01, 2019 - We also searched regulatory data and scientific publications for data about harms. … Harms were rare and trials underpowered to assess harms for all interventions. … Across interventions, data are sparse to evaluate long-term improvements and risk of harms.
-
effectivehealthcare-admin.ahrq.gov/products/type-2-diabetes-medications-update/research
December 01, 2019 - The objective of this review was to summarize the benefits and harms of medications (metformin, second-generation … intermediate outcomes (e.g., hemoglobin A1c [HbA1c]), long-term clinical outcomes (e.g., mortality), and harms … Conclusions
Comprehensive information comparing benefits and harms of diabetes medications can facilitate … Although the long-term benefits and harms of diabetes medications remain unclear, the evidence supports
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/my-nomination-is-about-comparing-outcomes-of-different-glaucoma-treatments-particularly-canaloplasty-to-trabeculectomy-and-to-medical-therapy-alone
November 01, 2017 - well the test, treatment, or intervention works
There is significant potential for side effects/harms … or diagnosis/identification for a particular disease, or risk assessment for a disease
Risks or harms … a condition or particular system of care
Delivery of a health service
Referral
Risks or harms … Harms: Are there risks, side effects, or harms you are concerned about?
-
effectivehealthcare-admin.ahrq.gov/products/cancer-pancreas/research-protocol
January 01, 2020 - Fifth, harms are always a concern; by estimating the actual rates of the various harms of different imaging … We changed KQ 3 (harms) to “rates of harms” rather than simply “harms” to clarify the focus on how common … the harms are, not simply what the possible harms are. … Key Question 3 on the rates of procedural harms . … For harms (KQ 3), there is a statement in the Methods section that harms/complications would be measured
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-240-acute-pain-evidence-summary.pdf
December 01, 2020 - Evidence did not suggest an
increased risk of serious harms for any intervention, though studies were … not designed to
assess serious harms. … Evidence on how benefits or harms varied in subgroups
was lacking. … Additionally, trials
were not designed to evaluate how benefits and harms varied in subgroups. … acute pain
on non-pain outcomes; effects of therapies on long-term outcomes; and how benefits and
harms
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
April 01, 2020 - • Efficacy and harms of prescription drug
treatment for CATD:
– In adults with mild to moderate … or supplements for
cognition, function, and harms in CATD. … Evidence on the efficacy and harms of CATD
drugs had several limitations. … Harms reporting was poor. … Studies should systematically
collect data on potential harms of cognitive testing.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pwd-care-interventions-protocol.pdf
February 22, 2019 - While nondrug interventions are
generally presumed safe, few trials have reported information on their harms … in
People With Dementia (PWD)
• KQ1: For people with dementia (PWD), what are the benefits and harms … • KQ7: For people with dementia (PWD), what are the benefits and harms for care
interventions aimed … Societal costs, including caregiving
time/time spent on activities
Harms, including isolation, … for quality of life,
function, or non-BPSD symptoms in PWD
KQ 5-6: Evaluate benefits and harms of
-
effectivehealthcare-admin.ahrq.gov/products/breast-reconstruction-mastectomy/protocol
July 01, 2021 - Specifically, the review will address the (comparative) benefits and harms of:
IBR versus AR (Key … undergoing (or have undergone) mastectomy for breast cancer, what are the comparative benefits and harms … We expect to summarize harms data semiquantitatively (i.e., without meta-analysis). … We expect to primarily rely on reported within-study differences in effects (or harms). … For KQ 6 (flap types for AR) we will also include in the SoE tables harms to area of flap harvest.
-
effectivehealthcare-admin.ahrq.gov/products/care-interventions-pwd/protocol
August 01, 2020 - KQ2: For informal and/or formal PWD Caregivers , what are the benefits and harms for care interventions … KQ4: For informal and/or formal PWD Caregivers , what are the benefits and harms for care interventions … KQ7: For people with dementia ( PWD ), what are the benefits and harms for care interventions aimed at … Study Objective
KQ 1–3: Evaluate benefits and harms of care interventions for BPSD symptoms in PWD … symptoms in PWD
KQ 5–6: Evaluate benefits and harms of care interventions for quality of life and
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0264_01-14-2008.pdf
January 01, 2008 - NSAIDs (these are rarely used alone and have no disease-modifying
properties))
Outcome(s): Potential harms … For children with juvenile idiopathic arthritis, do drug therapies differ in harms,
tolerability, adherence … What are the comparative benefits and harms of drug therapies for juvenile
idiopathic arthritis in
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/assessing-the-risk-of-bias_draft-report.pdf
June 02, 2011 - (CONSORT Harms extension, 2004).
24
For a
detailed explanation of terms associated with harms please … Although reviewers
recognize the importance of harms outcomes, harms are generally ignored in quality … The McMaster University Harms scale (McHarm) tool was developed specifically for
evaluating harms and … Was the mode of harms collection specified as ACTIVE?
6. … Did the study specify WHO collected the harms?
8.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
July 01, 2013 - The quality of harms reporting was assessed using the
USPSTF rating, with specific attention to both … , underreporting or inconsistent reporting
of harms.
6
Two reviewers independently assessed the … Efficacy Outcome Harms Outcome
1. … Agreed-upon reporting
standards for effectiveness and harms outcomes are
needed. … McMaster Quality Assessment Scale
of Harms (McHarm) for Primary Studies.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ems-blood-transfusion-protocol.pdf
September 24, 2024 - Are the benefits and harms modified by:
4
i. … Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i.
-
effectivehealthcare-admin.ahrq.gov/products/social-isolation/protocol
December 01, 2019 - Among older adults, what are the harms associated with interventions (e.g., volunteerism, peer support … limited to Emergency Department visits, hospitalizations, primary and specialty care appointments)
Harms … arrow labeled "Question 2" connects "Interventions that target social isolation and loneliness" to harms … 2023-2024
Rapid Evidence Product
Feb 01, 2024
Deprescribing To Reduce Medication Harms
-
effectivehealthcare-admin.ahrq.gov/products/clinical-care/protocol
August 01, 2024 - Evidence Reports
Making Healthcare Safer IV: Programs for Responding to Harms … SHARE:
Making Healthcare Safer IV: Programs for Responding to Harms … Review Questions
How effective are programs for responding to harms … Contextual Questions How do such programs prevent or mitigate harms? … Project Timeline
Making Healthcare Safer IV: Programs for Responding to Harms Experienced by Patients
-
effectivehealthcare-admin.ahrq.gov/products/infantile-hemangioma/clinician
December 01, 2019 - systematic review evaluating the evidence regarding the efficacy, comparative effectiveness, and harms … However, few studies have assessed potential long-term harms as- sociated with beta-blocker use in infants … There was moderate SOE that steroids were associated with harms -- some of which may be short lived - … Evidence related to the effectiveness and harms of beta-blockers other than propranolol and timolol for … Few studies have assessed the potential long-term harms associated with using beta-blockers to treat